BackAchieve Life Sciences Overview
Achieve Life Sciences Inc.

Achieve Life Sciences Target Price

Analysts' average 12-month price target for Achieve Life Sciences is $16.

Get informed when a big investor buys or sells

+ Follow

Share Price

$7.06

Average Target Price

$15.75123.1% upside

4 analysts in the last 4 months

High: $20 | Low: $12

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-13Morgan StanleyMaxwell Skor$1384.1% upsideOpen
2026-08-12Raymond JamesRyan Deschner$18155% upsideOpen
2026-08-12H.C. WainwrightBrandon Folkes$1270% upsideOpen
2026-06-26Raymond James$20183.3% upsideOpen
2026-04-20Canaccord Genuity$1384.1% upsideOpen
2024-05-13OppenheimerFrancois Brisebois$5.522.1% downsideOpen
2022-11-16Maxim Group$443.3% downsideOpen

Achieve Life Sciences (ACHV) FAQ

As of the most recent data, ACHV shows a target price of $16. Scroll down for historical charts and peer comparison views.

If Achieve Life Sciences moved to the average analyst target of $16, shares would be roughly 123.1% higher than $7.06. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Achieve Life Sciences's earnings trajectory.

Besides this target price page, Stockcircle has Achieve Life Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $16) with ownership activity and broader fundamentals.

Achieve Life Sciences's target price is $16; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.